"DOJ Slams Industry's Bid to Stall Medicare Drug Price Talks"
The Department of Justice (DOJ) has criticized the Chamber of Commerce's attempt to block the Medicare drug price negotiation program, arguing that the organization lacks standing and that pausing the program would harm the public. The DOJ stated that companies won't feel the impact of negotiated prices until 2026 and that the case could be fully litigated by then. The DOJ emphasized the voluntary nature of the program and argued that pausing it would hinder efforts to control Medicare spending and make drugs more affordable for seniors. The Chamber of Commerce, along with other organizations, is suing the Department of Health and Human Services over the negotiation program.